New data on the effectiveness of its coronavirus pill was recently published by Pfizer.
According to this, its pill is up to 90% effective against hospitalization and death in patients belonging to vulnerable groups of the population.
In fact, as it became known, it maintains its effectiveness against the Omicron mutation.
Pfizer is used in combination with ritonavir every 12 hours for five days immediately after the first symptoms.
Once approved, it will be released under the Paxlovid brand.